Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis

IntroductionVenous thromboembolism (VTE) occurrence in patients with lung cancer is associated with significant morbidity and mortality. The Khorana Score (KRS) is a validated risk stratification tool developed to estimate risk of VTE in patients with cancer that incorporates clinical and laboratory...

詳細記述

書誌詳細

主要な著者:	Sean C. Dougherty, Rishika Singh, Caleb McKinney, Aditya Singh, Jack Masur, Alia C. Lynch, Ryan D. Gentzler, Wendy Novicoff, Nathan Roberts, Richard D. Hall
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2026-01-01
シリーズ:	Frontiers in Oncology
主題:	khorana risk score non-small cell lung cancer oncogenic driver mutation small cell lung cancer venous thromboembolism
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651192/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!